Go or no-go for treat-to-target in axial spondyloarthritis?

For almost a decade, treat-to-target (T2T) has been advocated as a management strategy for axial spondyloarthritis (axSpA), despite a lack of trial evidence. Recently, the first and only published T2T trial in axSpA did not meet its primary endpoint. The purpose of this review is to discuss whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Webers, Casper, Been, Marin, van Tubergen, Astrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
SPONDYLOARTHRITIS INCLUDING PSORIATIC ARTHRITIS: Edited by Joerg Ermann
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241428/
https://www.ncbi.nlm.nih.gov/pubmed/37071063
http://dx.doi.org/10.1097/BOR.0000000000000941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241428/
https://www.ncbi.nlm.nih.gov/pubmed/37071063
http://dx.doi.org/10.1097/BOR.0000000000000941

Ejemplares similares